MolNFT v1 · #17853 · protein
Structure of human dck complexed with 2'-deoxycytidine and ADP, P 43 21 2 space group
1P61 · Deoxycytidine kinase: “Structure of human dck complexed with 2'-deoxycytidine and ADP, P 43 21 2 space group”. X-ray diffraction, 2 ligands (ADP, DCZ), 2 pockets (best druggability 0.65). MolNFT v1 #17853 on GenesisL1: 3D structure…
- PDB
- 1P61
- Type
- protein
- Length
- 229 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Deoxycytidine kinase
- EC
- 2.7.1.74
- UniProt
- P27707
- Ligands
- ADP, DCZ
- Pockets
- 2 · best druggability 0.65
Structure
x-ray diffraction · 1 distinct chain · 56% helix, 11% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| B | Deoxycytidine kinase (EC 2.7.1.74) | protein | 229 | 56% helix, 11% strand | P27707 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 200 | 0.65 | 0.84 | 34 | ADP, DCZ |
| 2 | 55 | 0.30 | 0.75 | 14 | empty |
Compared structures
- 1P61 · Structure of human dCK complexed with 2'-Deoxycytidine and ADP, P 43 21 2 space group · the same entry in another collection · chain B against B, TM-score 1.00
- P27707 · AlphaFold monomer V2.0 prediction for deoxycytidine kinase (P27707) · a predicted model of the same protein · chain B against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P27707
- Elsewhere: RCSB PDB 1P61 · PDBe 1P61 · UniProt P27707
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.